Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials
- Publication date
- 1 January 2020
- Publisher
- 'Springer Science and Business Media LLC'